Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Most patients with HCC have advanced disease at initial diagnosis, and sorafenib has been the only systemic treatment option for more than a decade in patients with advanced, unresectable HCC. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Storandt, Michael H, Mahipal, Amit, Tella, Sri Harsha, Kommalapati, Anuhya, Jin, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719284/
https://www.ncbi.nlm.nih.gov/pubmed/36471742
http://dx.doi.org/10.2147/JHC.S365002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719284/
https://www.ncbi.nlm.nih.gov/pubmed/36471742
http://dx.doi.org/10.2147/JHC.S365002

Ejemplares similares